Mutation of V896M in cardiac myosin binding protein-c gene in two Chinese families with hypertrophic cardiomyopathy

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 759-763

  Wang, Ai Ling ^a   Kong, De Hua ^a   Chen, Duo Xue ^a   Jun, Wan ^a   Yu, Yuan Xun ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Transportation Information Center of Anhui Province   (China)

Author keywords

Gene; Hypertrophic cardiomyopathy; Mutation; V986M

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; PEDIGREE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 78049489558     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.333     Document Type: Article

References (14)

1. Maron BJ: Hypertrophic cardiomyopathy. A systematic review. JAMA 287: 1308-1320, 2002.
2. Olivotto I and Cecchi F: The epidemiologic evolution and present perception of hypertrophic cardiomyopathy. Ital Heart J 4: 596-601, 2003.
3. Zou Y, Song L, Wang Z, et al: Prevalence of idiopathic hypertrophic cardiomyopathy in china: a population-based echocardiographic analysis of 8080 adults. Am J Med 116: 14-18, 2004.
4. Maron BJ, McKenna WJ, Danielson GK, et al: A report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines. Eur Heart J 24: 1965-1991, 2003.
5. Girolami F, Olivotto I, Passerini I, et al: A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med 7: 601-607, 2006.
6. Watkins H: Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management. Eur Heart J (Suppl 3): L43-L50, 2001.
7. Flashman E, Redwood C, Moolman-Smook J, et al: Cardiac myosin binding protein C: its role in physiology and disease. Circ Res 94: 1279-1289, 2004. (Pubitemid 38724473)
8. Miyamoto CA, Fischman DA and Reinach FC: The interface between MyBP-C and myosin: site-directed mutagenesis of the CX myosin-binding domain of MyBP-C. J Muscle Res Cell Motil 20: 703-715, 1999.
9. Welikson RE and Fischman DA: The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells. J Cell Sci 115: 3517-3526, 2002.
10. Moolman-Smook JC, De Lange WJ, Bruwer ECD, et al: The origins of hypertrophic cardiomyopathy causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet 65: 1308-1320, 1999.
11. Richard P, Charron P, Carrier L, et al: Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy. Circulation 107: 2227-2232, 2003.
12. Jääskeläinen P, Kuusisto J, Miettinen R, et al: Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. J Mol Med 80: 412-422, 2002. (Pubitemid 34754207)
13. Richard P, Villard E, Charron P, et al: The genetic bases of cardiomyopathies. J Am Coll Cardiol 48: A79-A89, 2006.
14. Feng J, Wang AL, Cheng ZP, et al: Analysis of 18 and 20 exon of MYH7 gene between patients with sporadic and familial hypertrophic cardiomyopathy in Anhui. Acta Universitaties Medicinalis Anhui (in Chinese with an English abstract) 42: 550-553, 2007.